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Enrichment of the exocytosis protein STX4 in
skeletal muscle remediates peripheral insulin
resistance and alters mitochondrial dynamics
via Drp1
Karla E. Merz1,2,4,6, Jinhee Hwang1,6, Chunxue Zhou1, Rajakrishnan Veluthakal1, Erika M. McCown1,
Angelica Hamilton1, Eunjin Oh1, Wenting Dai1, Patrick T. Fueger 1,3, Lei Jiang 1, Janice. M. Huss1,5 &
Debbie C. Thurmond 1 ✉

Mitochondrial dysfunction is implicated in skeletal muscle insulin resistance. Syntaxin 4
(STX4) levels are reduced in human diabetic skeletal muscle, and global transgenic enrichment of STX4 expression improves insulin sensitivity in mice. Here, we show that transgenic
skeletal muscle-speciﬁc STX4 enrichment (skmSTX4tg) in mice reverses established insulin
resistance and improves mitochondrial function in the context of diabetogenic stress. Speciﬁcally, skmSTX4tg reversed insulin resistance caused by high-fat diet (HFD) without
altering body weight or food consumption. Electron microscopy of wild-type mouse muscle
revealed STX4 localisation at or proximal to the mitochondrial membrane. STX4 enrichment
prevented HFD-induced mitochondrial fragmentation and dysfunction through a mechanism
involving STX4-Drp1 interaction and elevated AMPK-mediated phosphorylation at Drp1 S637,
which favors fusion. Our ﬁndings challenge the dogma that STX4 acts solely at the plasma
membrane, revealing that STX4 localises at/proximal to and regulates the function of
mitochondria in muscle. These results establish skeletal muscle STX4 enrichment as a
candidate therapeutic strategy to reverse peripheral insulin resistance.
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iabetes affects over 400 million people worldwide, and this
number has quadrupled since 1980 (World Health
Organization)1. Prediabetes is also on the rise, and half of
prediabetic individuals develop type 2 diabetes within 5 years2.
Prediabetic individuals suffer from elevated blood glucose levels,
ranging from 100 to 125 mg/dl, or impaired glucose tolerance.
Importantly, prediabetes is reversible; however, current treatments are limited to exercise and dietary modiﬁcations. As such,
new insulin-sensitising therapeutics are urgently needed2. This
problem is quickly becoming a crisis, especially as many of the
drugs that have been used over the last decade for type 2 diabetes,
such as thiazolidinediones, are being withdrawn from the market
due to side effects. Therapies that block the progression from
prediabetes to type 2 diabetes are especially of interest and a top
priority3.
In prediabetic and healthy individuals, the skeletal muscle is
responsible for over 80% of glucose clearance4. Despite the
essential role of the skeletal muscle in glucose homeostasis, no
directed therapeutics have been developed to restore glucose
utilisation speciﬁcally in prediabetic skeletal muscle. We previously showed that global upregulation of the exocytosis protein
STX4 (gbSTX4tg) causes a twofold increase in glucose uptake,
implicating skeletal muscle STX4 in the preservation of glucose
homeostasis5,6. STX4 mRNA levels are decreased by ~15% in
skeletal muscle of diabetic versus healthy mice7, suggesting that
restoring STX4 expression may improve or restore glucose
homeostasis. However, whether targeting STX4 only in skeletal
muscle is sufﬁcient to improve whole-body glucose utilisation is
unknown.
The mechanism linking STX4 enrichment and increased skeletal muscle glucose uptake is thought to involve interaction
between STX4 and its cognate Soluble N–ethylmaleimide sensitive factor (NSF) attachment receptor (SNARE) protein partners
at the plasma membrane. This interaction facilitates the translocation and fusion of glucose transporter 4 (GLUT4)-bound
vesicles with the plasma membrane, thereby increasing insulinstimulated glucose uptake into the muscle cell8. STX4 is the key
regulator of GLUT4 vesicle fusion at the plasma membrane in
skeletal muscle5. Consistent with this, gbSTX4tg increases plasma
membrane GLUT4 density in mice5,6. However, the repertoire of
STX4 functions has recently expanded beyond mediating SNARE
exocytosis in other cell types9. Hence, it is not known whether
STX4-mediated regulation of GLUT4 translocation in skeletal
muscle cells is the only mechanism underlying its ability to preserve glucose homeostasis.
Mitochondrial disruption is becoming increasingly recognised
as a prominent mechanism underlying progression to diabetes.
Under high-fat diet (HFD) conditions, mice exhibit increased
mitochondrial ﬁssion and mitophagy10, with mitochondria
appearing vacuolised with unstructured cristae11. Mitochondrial
ﬁssion is controlled by dynamin-related protein (Drp1), which
undergoes several post-translational modiﬁcations that regulate
its function12. In particular, phosphorylation of Drp1 at Ser616
(S616) activates mitochondrial ﬁssion13, whereas phosphorylation
of Drp1 at Ser637 (S637) inhibits mitochondrial ﬁssion14,15.
Phosphorylation of Drp1 at S637 by protein kinase A (PKA), or
by AMP-activated protein kinase (AMPK)16,17, inhibits Drp1
translocation from the cytosol to mitochondria, inhibiting mitochondrial ﬁssion. Interestingly, exercise, which can reverse prediabetes, increases pDrp1S637 phosphorylation17. Consistent with
a pro-diabetes role for Drp1-mediated mitochondrial ﬁssion,
skeletal muscle-speciﬁc knockout of calcineurin (an endogenous
inhibitor of PKA) yields elongated mitochondria, and confers
resistance to HFD-induced obesity18. Furthermore, in islet
beta cells, AMPK can phosphorylate Drp1 at S637 and prevent
changes in mitochondrial morphology in response to
2

diabetogenic stimuli16. However, whether STX4 regulates mitochondrial ﬁssion is unknown.
The aims of the present study were to evaluate whether transgenic
skeletal muscle-speciﬁc STX4 enrichment (skmSTX4tg) is sufﬁcient
to improve insulin sensitivity and whether the mechanism involves
mitochondrial regulation. We demonstrate that skmSTX4tg in mice
reverses established insulin resistance, and improves mitochondrial
function in response to diabetogenic stress. STX4 associates with
Drp1 and mediates Drp1 phosphorylation at S637 in a mechanism
involving AMPK in the skeletal muscle. These provocative ﬁndings
support the notion that skeletal muscle-speciﬁc intervention is sufﬁcient to reverse diet-induced insulin resistance, a ﬁnding with
potential therapeutic implications. They also challenge the view that
STX4 acts solely at the plasma membrane and unveil a role for STX4
being on or proximal to the surface of the mitochondria.
Results
Skeletal muscle-speciﬁc enrichment of STX4 enhances glucose
homeostasis in mice. We generated skmSTX4tg mice on the
C57Bl/6 J background, using a Tet-on inducible system to
selectively drive Stx4 expression under the control of a modiﬁed muscle creatine kinase (Mck) promoter in response to
doxycycline (Dox) in the food or water (Fig. 1a). Dox treatment
(2 mg/ml in drinking water) starting at 12 weeks until 25 weeks
of age, increased STX4 levels in the skeletal muscle but not the
heart (Fig. 1b, p = 0.037), as expected19. Both insulin sensitivity (intraperitoneal insulin tolerance test, IPITT) and glucose tolerance (intraperitoneal glucose tolerance test, IPGTT)
were enhanced in skmSTX4tg female mice (STX4) compared to
age-matched (4–6 months old) female non-Dox-induced
(CTRL) mice (Fig. 1c, d; increase in IPITT area over the
curve [AOC], p = 0.007; and decrease in IPGTT area under the
curve [AUC], p = 0.012). Plasma insulin content sampled
during the earliest time point (10 min) of the IPGTT were
0.37 ± 0.11 ng/ml for CTRL and 0.36 ± 0.08 ng/ml for STX4. In
male mice, STX4-induced enhancement of IPGTT or IPITT did
not reach the signiﬁcance threshold (Suppl. Fig. 1a, b);
enhanced insulin sensitivity in male C57Bl6 mice can be mild
by IPITT/IPGTT, requiring clamp analyses to reveal the
enhanced insulin sensitivity5,20. Single transgenic controls
(TRE-STX4 or Mck-rtTA) on Dox, which do not overexpress
STX4, showed no change in insulin sensitivity (Suppl. Fig. 1c).
SkmSTX4tg did not alter body weight, body composition or
organ weights (Fig. 1e, f, Suppl. Table 1). These data recapitulate the phenotypes observed in gbSTX4tg mice6, suggesting
that STX4 enrichment in the skeletal muscle alone of female
mice is sufﬁcient to increase insulin sensitivity and glucose
tolerance.
The plasma insulin levels in skmSTX4tg female mice were
lower than those in CTRL mice after fasting for 6 hours (Fig. 1g);
there was a similar trend at 16 hours, though the magnitude was
smaller and the difference did not reach the signiﬁcance threshold
(Suppl. Fig. 1d). We investigated multiple potential explanations
for this unexpected effect of a muscle-speciﬁc intervention on
plasma insulin levels, which are regulated by the pancreatic beta
cells. For instance, decreased plasma insulin levels could result
from islet cell damage. However, islet function was not decreased
—indeed, acute glucose-stimulated insulin secretion (GSIS)
ex vivo was enhanced in islets from skmSTX4tg mice relative to
CTRL; the islet beta cell mass and islet insulin content were
not affected (Fig. 1h, i, Suppl. Fig. 1e). Alternatively, STX4
enrichment-induced insulin sensitivity in the muscle could
induce the release of a myokine-type factor that modulates
beta cell response, as has been described21,22. To test whether
STX4 enrichment induces the release of a myokine-like factor, rat
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skeletal muscle L6 myoblasts were transiently transfected to
overexpress STX4 or control DNA (empty vector), and the
conditioned media (CM) taken from these skeletal muscle
cultures was provided to rat beta cells (INS-1 832/13). No
differences in baseline (1 mM glucose) or glucose-stimulated
(20 mM glucose) insulin release were detected from beta cells
treated with Ctrl- vs. rSTX4-enriched CM (Fig. 1j). Moreover, no
differences in the plasma levels of glucagon, cholesterol,
triglycerides or adiponectin were evident between skmSTX4tg

and CTRL mice fasted for 16 h (Suppl. Fig. 1f–i). The abundances
of pTyr608IRS1 and pSer473AKT, which represent early events in
the insulin signalling cascade, were also similar between STX4enriched and Ctrl L6 muscle cells, and between STX4-enriched
and CTRL muscle (Suppl. Fig. 1j–l). Although the precise
mechanism remains unknown, this phenotypic proﬁle of reduced
plasma insulin and enhanced islet function is similar to the
phenotype of exercise-trained mice, which also show improved
glucose homeostasis23.
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Fig. 1 Skeletal muscle-speciﬁc STX4 enrichment boosts peripheral insulin sensitivity in female mice. a A schematic map of the Tet-On doxycycline
(Dox)-inducible model of skeletal muscle-speciﬁc STX4 overexpression. b Immunoblot of mouse skeletal muscle showing an increase in STX4 expression
in Mck-rtTA:TRE-Stx4 mice with 2 mg/ml Dox delivered in drinking water. Heart lysates are shown as a negative control. Quantitation of n = 5 mice/group
is shown in bar graph to the right. *p = 0.0367 by paired two-tailed t-test. c Intraperitoneal insulin tolerance test (IPITT). The bar graph shows data
expressed as area over the curve (AOC), [CTRL, n = 5; STX4, n = 7]. P values *15 min=0.0367; *60 min=0.0284; **p = 0.0067 by unpaired two-tailed t
test. d Intraperitoneal glucose tolerance test (IPGTT). The bar graph shows data expressed as area under the curve (AUC), [CTRL, n = 6; STX4, n = 8].
P values **15 min=0.0054; *30 min=0.0180; *90 min=0.0315; *p = 0.0109 by unpaired two-tailed t-test. e Body weight (CTRL: Mck-rtTA:TRE-Stx4
without Dox; STX4: Mck-rtTA;TRE-Stx4 with Dox), [CTRL, n = 6; STX4, n = 6]. f Body composition. Grey: lean mass; yellow: fat mass. [CTRL, n = 7; STX4,
n = 8]. g Fasted plasma insulin levels in mice fasted 6 h. *p = 0.0109 by unpaired two-tailed t-test. h Stimulation index (glucose-stimulated insulin release/
basal) from ex vivo pancreatic islets, normalised to % insulin content [CTRL, n = 6; STX4, n = 6], *p = 0.0272 by unpaired one-tailed t-test. i Beta cell
mass (n = 4/group), scale bar=50 µm. Panels b–i: data are mean ± SEM (4–6 months old). j Insulin release from INS-1 832/13 beta cells treated with
conditioned media from skeletal muscle L6 cells overexpressing rat (r)STX4 or vector control (Ctrl) using different passages of L6 and INS-1 832/13 cells
(Ctrl, n = 8; rSTX4, n = 6). Error bars denote mean ± SEM. **p = 0.004; *p = 0.0444 by One-way ANOVA with Tukey’s post hoc test. Source data are
provided as a Source Data ﬁle.

STX4 enrichment in skeletal muscle can reverse high-fat-dietinduced insulin resistance. Given that skmSTX4tg was sufﬁcient
to improve glucose homeostasis in vivo, we asked whether
skmSTX4tg could also remediate HFD-induced insulin resistance.
To test this, we developed an insulin resistance rescue paradigm
in which a ‘western diet’ model with 45% of kcal from fat was fed
to mice for a brief time (10 weeks) to ﬁrst stage assessment of
insulin resistance. The resulting insulin resistant mice were used
in the rescue stage to test the capacity of STX4 enrichment to
reverse insulin resistance. Previous work has shown that young
female mice do not develop signiﬁcant insulin resistance in this
time frame on 60% HFD paradigms24–28. Since the basis for the
rescue study requires that all groups develop peripheral insulin
resistance by the end of the ﬁrst stage, female mice were not
included in the HFD trials. Male mice (8 weeks old) carrying one
of both transgenes were fed the HFD and were evaluated for
insulin resistance via IPITT at 18 weeks of age (Fig. 2a). Insulin
resistance was deﬁned as failure of insulin to lower blood glucose
levels by 40% within 60 min in 6-hour-fasted mice. The most
insulin resistant mice were provided Dox-containing HFD to
induce STX4 expression in the skeletal muscle (HFD + STX4
group), intentionally providing the most stringent challenge for
testing the reversal capacity of STX4. The remaining mice were
maintained on the HFD without Dox (HFD group). After 4
additional weeks (22 weeks old), the HFD and HFD + STX4 mice
were re-assessed for insulin resistance (Fig. 2a). We observed
increased insulin sensitivity (increase in AOC for the IPITT) in
100% (7 out of 7) of the HFD-fed skmSTXtg mice after 4 weeks of
Dox induction (Fig. 2b, p = 0.02), demonstrating that skeletal
muscle STX4 can remediate insulin resistance in HFD-fed mice,
despite the continued intake of a diabetogenic diet. In contrast,
there were no overall trends toward increased insulin sensitivity
in the HFD group (p = 0.84) over the same 4-week period
(Fig. 2c); single transgenic controls also showed no differences in
insulin sensitivity (Suppl. Fig. 2a). At 22 weeks, only 4 weeks after
initiation of STX4 induction, the insulin sensitivity of the HFDfed skmSTX4tg mice was indistinguishable from that of agematched chow-fed mice (Fig. 2d). SkmSTX4tg expression did not
impact weight gain, body composition, or caloric intake after
HFD feeding (Fig. 2e–h). These results indicate that STX4
enrichment in skeletal muscle can restore insulin sensitivity in a
manner independent of adiposity or body weight.
Chronic HFD feeding, in the absence of agents to protect beta
cells, causes islet dysfunction29. Consistent with this, HFD caused
persistent hyperinsulinemia and whole-body glucose intolerance,
and skmSTX4tg induction did not remediate these effects (Fig. 2i,
p = 0.04; Suppl. Fig. 2b, c). While STX4 is known to be protective
of beta cells9, our data show that the short term 4-week
4

overexpression of STX4 solely in skeletal muscle, initiated after
months of palmitate-based HFD exposure, may not be sufﬁcient
to elicit signiﬁcant improvement to beta cell function under
diabetogenic conditions, even though skeletal muscle expression
of STX4 is coupled to beta cell function under unstressed
conditions (Fig. 1h).
We also evaluated markers associated with overnutrition and
obesity. We observed HFD-induced hypercholesterolemia, as has
been reported30,31, in both HFD and HFD + STX4 mice (Suppl.
Fig. 2d). Furthermore, HFD caused changes to relative organ
weights, as described previously32, in both HFD and HFD +
STX4 mice (Suppl. Table 2). Plasma levels of glucagon,
triglycerides, non-esteriﬁed fatty acids (NEFA), and adiponectin
were similar among chow-fed, HFD and HFD + STX4 mice
fasted for 16 h (Suppl. Fig. 2e–h); hyperleptinemia was observed
in both HFD and HFD + STX4 mice (Suppl. Fig. 2i), consistent
with overnutrition-associated obesity33. In plasma from HFD and
HFD + STX4 mice fasted for only 6 h, plasma levels of insulin,
glucagon, triglycerides, free glycerol, leptin and adiponectin were
also similar (Suppl. Fig. 3a, b, d, e and g, h); however, plasma
cholesterol and NEFA were decreased in HFD + STX4 mice
relative to HFD mice (Suppl. Fig. 3c and f). Endurance exercise
also reduces circulating cholesterol and NEFA, consistent with a
model where the beneﬁts of STX4 enrichment and exercise share
similar mechanisms34,35.
STX4 enrichment in skeletal muscle can increase spontaneous
activity and respiratory exchange ratio. To assess the effects of
skmSTX4tg induction on metabolism and behaviour, the male
mice from the HFD cohorts were subsequently placed in metabolic caging units for an initial acclimatisation period of at least
24 h, followed by 24 h of parameter measurement. Chow-fed
mice had a respiratory exchange ratio (RER) averaging 0.88,
indicating a predominantly carbohydrate metabolic fuel source,
and HFD-fed mice had an average RER of 0.77, indicating that fat
was the predominant metabolic fuel (Fig. 3a), as has been previously described36. In contrast to the HFD mice, skmSTX4tg
induction in HFD-fed mice signiﬁcantly shifted the average
RER to above 0.81, indicating more carbohydrate use. This
skmSTX4tg-induced change in RER was accompanied with
decreased energy expenditure in HFD + STX4 mice compared to
chow-fed controls (Fig. 3b), suggesting that STX4-enriched mice
are more efﬁcient at expending energy (more active, but less
energy expenditure). Furthermore, spontaneous physical activity
at night (average distance travelled per hour=Distance K) was
lower in HFD-fed mice than in chow-fed mice, and the activity
levels in HFD + STX4 mice more closely resembled those of the
chow-fed mice than the HFD-fed mice (Fig. 3c); Distance K was
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Fig. 2 Skeletal muscle-speciﬁc STX4 enrichment of high-fat diet (HFD)-fed male mice reverses insulin resistance. a Schematic ﬂow: Eight-week-old
male Mck-rtTA:TRE-STX4 mice were placed on a 45% HFD for 10 weeks and the IPITT was used to conﬁrm insulin resistance (18 weeks old, pretreatment
IPITT). The skeletal muscle-speciﬁc STX4 transgene was induced using 625 mg/kg Dox in the HFD in half of the mice (HFD + STX4 group), while the
other half remained on only HFD (HFD group). After 4 weeks, the IPITT was performed again (22 weeks old, post-treatment IPITT). b IPITT AOC values for
HFD + STX4 mice (n = 7) pre- and post-treatment. *p = 0.0334 by paired two-tailed t-test. c IPITT AOC values for HFD mice (n = 8). No signiﬁcant
differences were detected by paired two-tailed t-test. d IPITT curves from HFD-fed mice at 18 weeks old (orange; pretreatments IPITT) and the same mice
after Dox treatment at 22 weeks old (green; post-treatment IPITT); chow-fed controls (black dashed) provided a reference point. Chow n = 5; HFD,
HFD + STX4 n = 7 each. P values ***15 min=0.0004; **30 min= p = 0.0013 by unpaired two-tailed t-test comparing HFD and HFD + STX4. e Cumulative
percent increase in body weight in HFD and HFD + STX4 animals [HFD, n = 9; HFD + STX4, n = 8]. f Body weight at 22 weeks old [HFD, n = 8;
HFD + STX4, n = 7]. g Body composition at 22 weeks old after Dox treatment [HFD, n = 8; HFD + STX4, n = 7]. h Average daily calorie consumption per
week over the HFD feeding period [HFD, n = 9; HFD + STX4, n = 8]. i Plasma insulin levels in mice at 24 weeks of age, after a 6-h fast [Chow, n = 7; HFD,
n = 7; HFD + STX4, n = 8]. Statistics calculated using one-way ANOVA with Tukey’s post hoc test, *p = 0.0298. Error bars in (d-i) represent mean ± SEM.
Source data are provided as a Source Data ﬁle.

not correlated with the effects of HFD on body fat or insulin
sensitivity (Suppl. Fig. 4a, b, p value = 0.36 and 0.30 respectively).
Nevertheless, these data suggest that skmSTX4tg induction is
sufﬁcient to partially rescue the effects of HFD feeding on
metabolism and fully remediate the effects on spontaneous
activity.

STX4 enrichment improves mitochondrial respiration and
regulates mitochondrial dynamics. HFD decreases mitochondrial number in human skeletal muscle37, changes mitochondrial
structure, and reduces oxidative phosphorylation38,39. Thus, we
assessed whether skmSTX4tg induction alters mitochondrial
structure and function. Using the Seahorse XFe24 ﬂux analyser to
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Fig. 3 Skeletal muscle-speciﬁc STX4 enrichment in HFD-fed mice impacts metabolism and spontaneous physical activity. Metabolic caging analyses of
the male mice used in the stages of the feeding paradigm of Fig. 2a; caging data were collected over 24–48 h. a Respiratory exchange ratio (RER) time-course
over 24 h, with corresponding area under the curve (AUC) calculated as the area under each curve and 0.7 set as the baseline. ****p < 0.0001; ++++p < 0.0001;
**p = 0.0077 by one-way ANOVA with Tukey’s post hoc test. b Energy expenditure time course over 24 h, with corresponding area under the curve calculation.
**p = 0.0080 by one-way ANOVA with Tukey’s post hoc test. c Average hourly spontaneous activity measured as Distance K during the day (6:00–18:00) and
night (18:00–6:00). All data in panels a-c are representative of Chow=8, HFD = 16, HFD + STX4 = 6. *p = 0.0120; **p = 0.0083 by one-way ANOVA with
Tukey’s post hoc test. d) Extracellular ﬂux analysis (Seahorse) to assess the mitochondrial oxygen consumption rate of HFD (n = 3, orange) and HFD + STX4
(n = 3, green) mice. Inset panel: plot of the change in maximal respiration between the HFD and HFD + STX4 groups. Box plots indicate median (middle line),
25th, 75th percentile (box) and minimum and maximum (whiskers). *p = 0.0158, 0.0493, 0.0217, 0.0291, 0.0256 from left to right, ***p = 0.0001 by unpaired
two-tailed t-test. Error bars in (a–d) represent mean ± SEM. Source data are provided as a Source Data ﬁle.

measure oxygen consumption rates, we determined that primary
myoﬁbers from HFD + STX4 mice had greater maximal mitochondrial respiration than myoﬁbers from HFD-fed mice
(Fig. 3d). To understand how STX4, a protein characteristically
found localised to the plasma membrane, may alter mitochondrial respiratory capacity, we used immunogold labelling with
high-resolution TEM to evaluate the subcellular localisation of
STX4 in the muscle. STX4 was localised not only to the myoﬁber
sarcolemma but also on or proximal to the surface of the outer
mitochondrial membrane (OMM) (Fig. 4a). The speciﬁcity of
antibody binding was conﬁrmed using a blocking peptide with
6

wild-type muscle and muscle from skmSTX4-KO (knockout)
mice, both of which eliminated the immunogold signal at the
mitochondrial membranes (Suppl. Fig. 4c). STX4 was also
detected in skeletal muscle mitochondrial fractions, further supporting the concept of STX4 being on or proximal to the surface
of the mitochondria (Suppl. Fig. 4d).
We next evaluated the structure of the mitochondria in the
tibialis anterior (TA) muscle using transmission electron microscopy (TEM). Changes in mitochondrial size and structure are
central to complications in obesity and diabetes, and HFD causes
an imbalance in mitochondrial fusion-ﬁssion, resulting in
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fragmentation, which increases vacuolisation and reduces cristae
uniformity11. Muscle mitochondria from the HFD mice appeared
fragmented and vacuolised (Fig. 4b, red arrows). By contrast, the
mitochondria in the HFD-fed skmSTX4tg muscles appeared very
similar to those in chow-fed mice, with little vacuolisation and
fragmentation. The mitochondrial area was signiﬁcantly larger in

HFD + STX4 skeletal muscle compared to that in HFD mice
(Fig. 4c). We also assessed other measures of mitochondrial
function, including mitochondrial DNA copy number and citrate
synthase activity. We observed no changes in these parameters
among muscles from the chow, HFD and HFD + STX4 groups
(Fig. 4d, e). In addition, we looked at potential changes in electron
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Fig. 4 Skeletal muscle-speciﬁc STX4 enrichment restores mitochondrial structure. a Immunogold STX4 labelling of intramyoﬁbullar (IMF) mitochondria
in the tibialis anterior (TA) muscle of STX4-enriched chow-fed male mice. STX4 particles are highlighted with yellow arrows, and a mitochondrion is
outlined in red. Scale bar=0.5 µm. b Representative TEM images of TA IMF mitochondria at a magniﬁcation of 4400X (top) and 11,000X (bottom), in
chow-fed, HFD-fed, and HFD + STX4 male mice. Scale bar=1 µm (4400X) and 200 nm (11,000X); mitochondria are indicated with yellow arrows, while
red arrows indicate mitochondrial vacuolisation. c Mitochondrial area measurements from 4 to 6 skeletal muscle areas, taken at 6500X, from HFD-fed
(n = 3) and HFD + STX4 (n = 4) mice. ****p < 0.0001 by unpaired two-tailed t-test). d Mitochondrial DNA (mtDNA) content, measured by comparing the
levels of Cox1 to 18 s ribosomal DNA, in chow-fed (n = 6), HFD-fed (n = 7) and HFD + STX4 (n = 9) male mice. DNA extracted from hindlimb. e Citrate
synthase activity after a 4.5 min reaction in hindlimb muscle of male chow-fed (n = 3), HFD-fed (n = 3), and HFD + STX4 mice (n = 4). Error bars in (c–e)
represent mean ± SEM. f Whole-hindlimb immunoblot of electron transport chain complexes I, II, III, IV and V, in chow-fed, HFD-fed, and HFD + STX4
male mice. Ponceau S was used as loading control. The blot shown is representative of n = 3 mice/group. Dashed vertical line indicates the splicing of a
lane from within the same gel exposure. g Representative TEM images of TA IMF mitochondria at a magniﬁcation of 4400X (top) and 11,000X (bottom),
in chow-fed CTRL and STX4 female mice. Bar=1 µm (4400X) and 200 nm (11,000X). h Mitochondrial area measurements from 4 to 6 skeletal muscle
images, taken at 6500X, from CTRL (n = 5) and STX4 (n = 6) mice. ****p < 0.0001 by unpaired two-tailed t-test). i Mitochondrial copy number in chowfed CTRL (n = 4) and STX4 (n = 5) female mice. *p = 0.0317 by unpaired two-tailed t-test) and j citrate synthase activity in chow-fed CTRL (n = 6) and
STX4 (n = 6) female mice. Error bars in h–j represent mean ± SEM. k Immunoblot of electron transport chain complexes in female chow-fed CTRL and
skmSTX4tg mice, representative of n = 6 mice/group. Ponceau S is used as a loading control. All TEM images are representative of 3–6 animals/group
with 4–6 ﬁelds of view evaluated per mouse muscle section, assessed in a blinded fashion by the microscopist. Mitochondrial areas were quantiﬁed using
Image J. Source data are provided as a Source Data ﬁle.

transport chain (ETC) proteins, which could contribute to
changes in mitochondrial function and morphology. Again, no
changes were observed among the chow, HFD and HFD + STX4
groups (Fig. 4f, Suppl. Figure 4e).
Having established the presence of mitochondrial disruption
under diabetogenic conditions, we decided to evaluate the chowfed skmSTX4tg mice for a similar phenotype. We found that the
chow-fed skmSTX4tg mice contained elongated mitochondria
with highly organised and structured cristae, compared with
chow-fed CTRL mice (Fig. 4g). These ﬁndings suggest that
skmSTX4tg enrichment increases mitochondrial elongation,
while in the context of diabetogenic stress, skmSTX4tg reverses
the fragmented phenotype. We observed a population of enlarged
mitochondria speciﬁcally in skeletal muscle sections from
skmSTX4tg mice compared to CTRL mice (Fig. 4h), similar to
what was found in HFD + STX4 skeletal muscle (Fig. 4c),
suggesting that STX4 may be regulating mitochondrial ﬁssion or
fusion. The mRNA expression levels for mitochondrial fusion
genes were similar for skmSTXtg and CTRL mice (Suppl.
Table 3). We did ﬁnd chow-fed female skmSTX4tg muscle had
elevated mtDNA levels (Fig. 4i), most likely due to the enlarged
mitochondria, but there were no signiﬁcant changes across
groups in the citrate synthase activity or in ETC subunit levels
(Fig. 4j, k, Suppl. Figure 4f). These results were consistent with a
model wherein STX4 shifts the balance of mitochondrial ﬁssion
and fusion toward fusion.

STX4 overexpression does not impact TCA cycle metabolites in
skeletal muscle cells. To assess if STX4 affects mitochondrial
metabolism, we looked at tricarboxylic acid (TCA) cycle activity.
To do this, we used stable isotope tracing in L6 skeletal muscle
myoblasts overexpressing STX4 and compared to empty vector
controls. Isotopomer spectral analysis utilises [U-13C]glucose to
assess the enrichment of TCA cycle intermediates in cells. As the
labelled glucose tracer is metabolised, carbons from the glucose
are integrated into the downstream metabolites40. Isotopic
labelling can be measured for various metabolites, such as pyruvate, citrate, and glutamate. We compared the STX4overexpressing L6 (rSTX4) to Ctrl cells and ﬁnd that there is
no difference in the isotopic labelling between the two groups
(Suppl. Figure 5). This suggests that STX4 does not modify glucose metabolism in the cell under basal/ non- insulin-stimulated
conditions.
8

STX4 overexpression leads to increased Drp1 phosphorylation
at S637. The mitochondrial localisation of STX4 and its effects on
mitochondrial dynamics led us to assess whether skmSTX4tg
regulates the expression of proteins involved in mitochondrial
dynamics. We observed that STX4 overexpression decreased the
levels of Drp1, a regulator of mitochondrial ﬁssion, in hindlimb
muscles from mice fed chow or HFD (Fig. 5a, b). Given that Drp1
function is regulated by its phosphorylation state, we assessed
Drp1 phosphorylation in the mouse skeletal muscle and found a
signiﬁcant positive correlation between STX4 abundance and
Drp1 S637 phosphorylation, which enhances mitochondrial
fusion (Fig. 5c); however, there were no signiﬁcant changes in
Drp1 S616 phosphorylation, which enhances ﬁssion (Suppl.
Fig. 6a). To clarify the mechanism of action, we used L6 skeletal
myotubes overexpressing STX4, which show a characteristic
robust increase in glucose uptake upon insulin stimulation
(Suppl. Fig. 6b, c), mimicking the insulin-sensitising effects of
STX4 in skeletal muscle. STX4 overexpression in the L6 cells
increases pDrp1S637 (Fig. 5d), similar to the effect seen in mouse
skeletal muscle (Fig. 5c). To assess if STX4 is required for Drp1
S637 phosphorylation, we transiently transfected L6 myoblasts
with non-targeting (siCON) or STX4-targeting siRNA (siSTX4).
Compared to controls, siSTX4-treated skeletal muscle myoblasts
showed a signiﬁcant reduction in pDrp1S637 (Fig. 5e), which
supports the notion that STX4 is required for Drp1 phosphorylation at S637.
To evaluate the extent to which Drp1 modulation alters STX4
metabolic effects, seahorse analyses paired with western analysis
of phosphorylation changes to Drp1-S637 and -S616 were
performed in an independent set of L6 myoblast studies. We
initially demonstrated that STX4 knockdown alone (transient
transfection, siRNA) impairs maximal respiration (Suppl.
Fig. 6d). These ﬁndings complement those from gain-offunction studies in which STX4 overexpression increased
maximal mitochondrial OCR in HFD mice (Fig. 3d). STX4
knockdown phenocopies the effects of Drp1 overexpression (via
regulation of pDrp1-S637, and not S616) (Suppl. Fig. 6e–i).
Further, the decrease in pDrp1-S637 with STX4 knockdown
(even with Drp1 overexpression, Suppl. Fig. 6g) provide
additional support for the concept that STX4 regulates Drp1.
These results complement the other metabolism-based studies,
metabolic ﬂux studies using the same cells as well as the
metabolic caging studies of the mice, to demonstrate that STX4
modulation regulates mitochondrial function.
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STX4 regulates pDrp1S637 in a mechanism involving AMPK
but not PKA. PKA has been reported as the primary kinase for
Drp1 S637 phosphorylation41. To test whether STX4 increases
PKA activity to induce pDrp1S637, we treated cells with forskolin
(activates adenylyl cyclase to elevate cyclic AMP levels), in the

Mitochondria

presence and absence of STX4 enrichment or knockdown.
Changing STX4 expression did not affect PKA activity, either in
the presence or absence of forskolin (Suppl. Fig. 7a, b).
AMPK is also reported to phosphorylate Drp1 at S637,
preventing HFD-induced changes in the ER and in mitochondrial
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Fig. 5 STX4 enrichment leads to increased Drp1 phosphorylation at S637, through a mechanism involving AMPK. a Immunoblot of Drp1 levels in chowfed CTRL or STX4 whole-hindlimb extract. The bar graph shows quantitation of normalised immunoblots, n = 5-6/group. Dashed vertical line indicates
splicing of a lane from within the same gel exposure. *p = 0.0402 by unpaired two-tailed t-test. b Immunoblot of Drp1 levels in chow-fed (n = 5), HFD-fed
(n = 7), and HFD + STX4 (n = 11) whole-hindlimb extracts. Each chow served as a control on different gels to control for deviations in blotting/ECL
between gels. *p = 0.0374 by one-way ANOVA with Fisher’s LSD test. Error bars in (a and b) represent mean ± SEM. c Scatter plot of pDrp1S637
abundance vs. STX4 abundance in skeletal muscle, normalised to HPRT. d Skeletal muscle L6 myoblasts overexpressing rat (rSTX4) or vector control (Ctrl)
were immunoblotted for pDrp1S637 and total Drp1. Data expressed as a ratio of pDrp1S637/Drp1 (n = 5/group). **p = 0.0013 by unpaired two-tailed t-test.
e pDrp1S637 abundance in L6 skeletal muscle myoblasts expressing STX4 siRNA (siSTX4) or control (siCON). Data expressed as a ratio of pDrp1S637/Drp1
(n = 7/group). *p = 0.0415 by unpaired two-tailed t-test. f Effect of AICAR treatment on pDrp1S637 in siCON and siSTX4-treated L6 cells. Data expressed
as a ratio of pDrp1S637/Drp1 (n = 3/group). *p = 0.0492 by unpaired one-tailed t-test). g pAMPKThr172 abundance with STX4 knockdown (n = 6/group).
Data expressed as a ratio of pAMPKThr172/AMPK. *p = 0.0176 by unpaired two-tailed t-test. h pAMPKThr172 abundance upon AICAR treatment and STX4
knockdown (n = 3/group). Data expressed as a ratio of pAMPKThr172/AMPK. Error bars in (d–h) represent mean ± SEM. i Co-immunoprecipitation of
STX4 and Drp1 from skeletal muscle homogenates prepared from WT or skmSTX4-iKO mouse hindlimb muscle; representative of two sets of WT and KO
mouse homogenates. j Co-immunoprecipitation of STX4 and Drp1 from mitochondrial fractions prepared from WT mouse hindlimb muscle; representative
of three coIP experiments each using an independent set of mouse muscle mitochondrial fractions. k Schematic illustration of the mechanism of action of
STX4, Drp1, and AMPK at the mitochondria in skeletal muscle. Source data are provided as a Source Data ﬁle.

morphology16. We initially conﬁrmed that AICAR, an AMPK
activator, could increase the levels of active AMPK
(pAMPKThr172) in L6 muscle cells (Suppl. Fig. 7c). Furthermore,
AICAR increased pDrp1S637 levels (Suppl. Fig. 7d), conﬁrming
the ability of AMPK to phosphorylate Drp1 at S637 in the muscle
cells. We then tested whether the presence of STX4 is required for
AICAR to induce pDrp1S637. STX4 knockdown blocked the
ability of AICAR to induce pDrp1S637 (Fig. 5f), consistent with
the concept that AMPK participates in the mechanism by which
STX4-mediated Drp1 S637 phosphorylation. In addition, siSTX4
can suppress AMPK activation (pAMPKThr172) (Fig. 5g), but this
can be over-ridden by AICAR (Fig. 5h). Together, these data are
consistent with a model wherein STX4 induces Drp1 S637
phosphorylation in a mechanism involving AMPK but not PKA.
To further assess the role of STX4 in Drp1 regulation, we
immunoprecipitated STX4 to evaluate whether STX4 associates
with Drp1. Drp1 was detected in STX4 immunoprecipitates from
wild-type skeletal muscle (WT), but not skmSTX4-iKO (KO)
muscle, and not in IgG control immunoprecipitates from WT
muscle (Fig. 5i). Co-immunoprecipitation reactions performed
using isolated WT mouse muscle mitochondrial fractions
similarly showed Drp1 detection in STX4 immunoprecipitates,
and not in IgG control immunoprecipitates (Fig. 5j). These results
support a model wherein STX4 localised on or proximal to the
mitochondria associates with Drp1 and, in a mechanism
involving AMPK, mediates Drp1 S637 phosphorylation (Fig. 5k).
Discussion
To the best of our knowledge, this study is the ﬁrst to show a
remediation of peripheral insulin resistance and the reversal of
the negative effects of HFD on spontaneous activity, by the
selective enrichment of a protein in skeletal muscle. We have
shown that STX4, a SNARE protein known for its regulation of
GLUT4 translocation and glucose uptake in skeletal muscle, is
capable, when enriched, of reversing established HFD-induced
insulin resistance. STX4-enriched mice showed a full restoration
to normal insulin sensitivity, despite on-going exposure to HFD.
This suggests that targeting STX4 might also reverse prediabetes
in humans, even in the continued presence of diabetogenic stress.
We also provide the unusual ﬁnding of STX4 being on or proximal to the mitochondrial surface and mediates mitochondrial
dynamics, reverting vacuolised, and fragmented mitochondria in
the HFD-fed mice, back to structured, round and organised
organelles. Furthermore, STX4 suppresses mitochondrial ﬁssion
through the phosphorylation of Drp1 in a mechanism
involving AMPK.
10

In this study, we used the most insulin resistant mice to be
Dox-induced for STX4 enrichment. While there is documented
heterogeneity in the severity of insulin resistance generated by
HFD paradigms42, the basis for the rescue study requires that all
groups develop peripheral insulin resistance by the end of the ﬁrst
stage; this approach is the most stringent way to assess the
therapeutic potential of STX4. This approach ensures that STX4
is tested on the animals experiencing the largest effects of diabetogenic stress. We chose a 45% HFD, which is more physiologically similar to the diabetogenic western diet43, whereas 60%
HFD is not physiologically relevant, and causes irreversible
pancreatic beta cell damage.
The current approaches to reverse prediabetes are limited to
exercise and dietary modiﬁcations. Our ﬁndings support that Stx4
enrichment in skeletal muscle may provide an insulin-sensitising
therapeutic approach. Although little is known about the links
between STX4 and exercise, there are intriguing parallels between
the effects of STX4 enrichment and those of endurance exercise
on skeletal muscle metabolism. For instance, both interventions
improve maximum respiratory capacity and change mitochondrial dynamics. Exercise induces mitochondrial elongation44,
similar to the effects of STX4. Exercise and STX4 enrichment also
both improve glucose tolerance and insulin sensitivity. In addition, exercise-trained mice show increased spontaneous activity
levels compared to untrained controls45, similar to the increased
spontaneous activity of the skmSTX4tg mice. However, if STX4 is
truly acting as an exercise mimetic, it is not doing so completely.
Mice remain obese after STX4 induction, whereas exercise causes
weight loss and reduced percentage of abdominal body fat45. This
could be due to the fact that the mice are maintained on the HFD,
and they display no changes in caloric intake, so the spontaneous
physical activity is not reducing their caloric load enough to lead
to weight loss.
Our ﬁnding that STX4 may localise to the OMM refutes the
long-standing concept that STX4 acts only at the plasma
membrane46,47. Moreover, skmSTX4tg also reduces HFDinduced mitochondrial fragmentation and decreases the
abundance of Drp1, a regulator of mitochondrial ﬁssion. A
hallmark of HFD-induced diabetes is increased mitochondrial
ﬁssion and mitophagy48. It is therefore possible that
skmSTX4tg remediates HFD-induced insulin resistance via
suppressing mitochondrial ﬁssion through Drp1 S637 phosphorylation. Nonetheless, the exact mechanism of how STX4 is
mediating mitochondrial ﬁssion remains to be determined. In
support of this ﬁnding, a recent report shows that STX4 can
localise to the mitochondrial membrane in a variety of other
cell types49.
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Furthermore, in this study, we have demonstrated that STX4
mediates mitochondrial dynamics by facilitating Drp1 phosphorylation at S637 through a mechanism involving AMPK. STX4enriched cells showed increased S637 phosphorylation of Drp1. In
contrast, knockdown of STX4 decreased pDrp1S637, and also
decreased AMPK activation. We show here that AMPK activation
increases Drp1 S637 phosphorylation in skeletal muscle; this phosphorylation event was previously only shown in beta cells16. In
addition, we show that STX4 is required for AMPK phosphorylation
of Drp1 at S637, as the effects of STX4 knockdown on Drp1 S637
phosphorylation cannot be rescued by AICAR treatment. Lastly, the
results of our co-immunoprecipitation experiments suggest that
STX4 associates with Drp1 in the mitochondrial fraction of wholehindlimb mouse muscle. Interestingly we found no effect of STX4
expression on pDrp1S616, although it has been reported that mitochondrial ﬁssion increases with HFD feeding10. However, it is
possible that we missed the window to capture pDrp1S616 changes,
as pDrp1S616 is a transient modiﬁcation and returns to baseline
phosphorylation levels within 3 hours of rest after acute exercise50.
Although this study provides critical mechanistic insight, we do
not know how STX4 regulates AMPK activation and Drp1 S637
phosphorylation. AMPK is controlled by the ratio of AMP to
ATP in the cell. The primary mechanism of AMPK activation,
especially in metabolic disease conditions, is by preventing
AMPK dephosphorylation by AMP, or by low ATP levels
(energetic stress). In addition, as a nutrient sensor, AMPK can be
activated by cellular glucose levels, and a recent study demonstrates that cellular glucose can activate AMPK regardless of the
AMP:ATP ratio51. Given that AMPK is a nutrient sensor, there
are several ways in which STX4 might regulate AMPK activation:
1) STX4 may modulate the AMP to ATP ratio in skeletal muscle
to activate AMPK, or 2) STX4 might activate AMPK independent
of AMP/ATP ratios via modulating cellular glucose levels. Given
that stable isotope tracing in skeletal muscle cells suggests that
STX4 enrichment does not affect glucose metabolites, we propose
that STX4 likely alters AMPK activity by regulating AMP/ATP
ratios or through an atypical mechanism. We plan to pursue the
detailed mechanism in future studies.
In conclusion, we have shown that induction of STX4 selectively in the muscle of HFD-fed, insulin resistant mice restores
insulin sensitivity to the level of chow-fed mice. Skeletal musclespeciﬁc overexpression of STX4 phenocopies that of the global
STX4 overexpressing mice, pointing to skeletal muscle as the
primary driver of whole-body insulin sensitivity. This work
supports further investigation of skeletal muscle STX4 enrichment as a therapy to prevent or reverse diabetes. We also found
that induction of STX4 in skeletal muscle of HFD-fed mice
reduces HFD-induced mitochondrial fragmentation via atypical
mechanism that involves STX4 localisation on or proximal to
mitochondrial membranes and regulation of Drp1 phosphorylation through a mechanism involving AMPK. However, the precise details of the mechanism are still required to elucidate the full
effect of STX4 enrichment in skeletal muscle and determine its
potential and validity as a prediabetic therapeutic.
Methods
Transgenic mice and feeding studies. All animal experiments were conducted in
accordance with the NIH Guide for the Care and Use of Laboratory Animals
(National Institutes of Health Publication no. 85-23, revised 1996) and approved by
the Institutional Animal Care and Use Committees of City of Hope National
Medical Center (Duarte, CA, USA; approval #15023). Single transgenic TRE-STX4
mice were generated on the C57BL6J background as described19. Mck-rtTA mice
were purchased from the Jackson Laboratory (Bar Harbor, ME, USA) and maintained on the same background. Double transgenic mice were heterozygous for
each transgene, obtained from heterozygous matings. Littermates were used as
controls. All experiments were repeated with at least 2–3 independent cohorts of
mice. Chow-fed mice were housed on Sani-Chip bedding in groups of 3–5 and fed
standard maintenance chow (13% of kcal from fat; PicoLab #5053) starting at
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4 weeks of age. In the HFD feeding paradigm, 8-week-old skmSTX4tg mice were
fed a custom diet (45% of kcal from fat, principally palmitate based; Research Diets
#D01030108) ad libitum for 10 weeks. The most insulin resistant mice were placed
on HFD supplemented with 625 mg Dox (45% of kcal from fat; Research Diets
#D17100202) for 4 weeks, whereas the remaining mice fed HFD were maintained
on the HFD without Dox. All HFD-fed mice were housed individually on SaniChip bedding, 12 h light, 12 h dark cycle; food was measured and changed twice
weekly and body weight was measured once a week. STX4 ﬂoxed (ﬂ/ﬂ) mice were
obtained from Dr. Sidney Whiteheart (University of Kentucky)52 and crossed with
human skeletal actin (HSA)-rtTA/TRE-Cre recombinase positive mice (JAX #
012433) to produce doxycycline-inducible STX4 ﬂ/ﬂ:Cre+ mice (KO, heterozygous
for Cre). Mice were treated with 2 mg/kg doxycycline in water to induce STX4
knockout.
Glucose and insulin tolerance testing. The IPGTT was conducted in 4–6-monthold mice fasted for 6 hours prior to experimentation (0800–1400 h) and housed
individually. The mice were injected (i.p.) with 2 mg/kg D-glucose, which had been
diluted in saline and ﬁltered. Blood glucose levels were measured immediately before
injection (0 min) and then at 15, 30, 60, 90, and 120 min after injection. Blood (2 µl
postinjection) was taken from the mouse tail and diluted with 5 µl saline, then loaded
into cuvettes and measured immediately using a HemoCue 120706 Glucose 201
Analyzer. Blood taken before injection was directly loaded into the cuvettes without
dilution. For the IPITT, after the blood was collected, the mice were injected
intraperitoneally with Humulin R (0.75 units/kg) (Eli Lilly & Co., Indianapolis, IN).
Blood taken thereafter was directly loaded into cuvettes without dilution.
Immunoblot analysis. Mouse whole-hindlimb was extracted and ﬂash-frozen
immediately in liquid nitrogen. The hindlimb was then lysed using NP-40 lysis
buffer (25 mM HEPES pH 7.4, 1% NP-40, 10% glycerol, 137 M NaCl, 1 mM
Na3VO4, 50 mM NaF, 10 mM NaPP, 10 µg/ml aprotinin, 5 µg/ml leupeptin, 1 µg/
ml pepstatin, 1 mM PMSF, and 1 µl of dithiothreitol added per 1 ml of lysis buffer).
The samples were rotated at 4oC for 5 min and centrifuged at 17,100 × g for 5 min.
The supernatant was collected and aliquoted into tubes to avoid freeze/thaw
protein degradation. The proteins were resolved on hand-casted 10% SDS-PAGE
gels, using 20 µg protein/sample/lane, and transferred onto PVDF membrane.
Membranes were immunoblotted for STX4 (custom antibody, 1:3000)53, Tubulin
(Sigma #T5168, 1:5000), Drp1 (Abcam #ab56788, 1:1000), pDrp1S637 (Cell Signaling, #4867 S, 1:1000), pDrp1S616 (Cell Signaling #3455, 1:1000) AMPK alpha
(Cell Signaling #2793, 1:2000) and pAMPKα T172 (40H9) (Cell Signaling # 2535,
1:1000) in TBST + 1% bovine serum albumin (BSA) with sodium azide. For the
secondary antibody, Goat Anti-Rabbit IgG (H L)-HRP Conjugate (Bio-Rad #1721019) or Goat Anti-Mouse IgG (H L)-HRP Conjugate (Bio-Rad #172-1011) (see
Suppl. Table 4 for detailed dilutions) was incubated with the blot for 1 h at room
temperature (RT). Chemiluminescence was documented using a Bio-Rad ChemiDoc Touch and an enhanced chemiluminescence kit (Amersham ECL Western
Blotting detection reagent, GE Healthcare #RPN2106). Images were analysed using
Image Lab ver 6.0.1 (Bio-Rad, Hercules, CA).
Cell culture. L6 GLUT4myc skeletal muscle cells (Kerafast cat# ESK202-FP) where
maintained using complete growth media (MEM-α medium supplemented with
10% foetal bovine serum [FBS] and 1% [v/v] antibiotic-antimycotic solution) at
37 oC and 5% oxygen. MEMα medium was purchased from Invitrogen (Carlsbad,
CA). In addition, blasticidin (Millipore sigma cat# 203350, 6 µl/ 15 ml media) was
added to each passage to select for GLUT4myc cells. Cells were transfected the
following day, using K2 transfection reagent: cells were pre-treated with K2 multiplier for 2 h at 10 µl/ml, then DNA (pcDNA3.1 or pcDNA3-STX4) was combined
with transfection reagent for 20 min in serum-free media, then the DNA-K2
mixture was added to each well. For siRNA treatment, RNAi Max was used
together with OptiMEM according to the manufacturer’s instructions at a concentration of 100 nM and added to each well in a drop-wise fashion. Transfected
cells were left overnight and fresh media was added. siSTX4 sequence: 5’TCACTTTTCTAGCTACCGA-3’ (Ambion). Forskolin (Sigma, cat# F3917) was
used at a ﬁnal concentration of 20 µM and added to the medium for 1 h. AICAR
was used at a ﬁnal concentration of 0.5 mM for 16 h. For insulin stimulation, cells
were starved using serum-free media for 50 min, then bovine insulin was added at a
ﬁnal concentration of 100 nM per well. To differentiate the cells, myoblasts were
seeded at 10,000 cells/ml into differentiation media (MEM alpha, 2% FBS, and 1%
antibiotic-antimycotic), for 7 days to completely differentiate. Upon complete
differentiation, the cells were transduced with Ad5-CMV-STX4 or Ad5-CMV
control virus for 72 h.
Morphometric assessment of islet cell mass. Mouse islet morphometry was
conducted using pancreatic sections stained with an antibody to insulin. In Brief,
pancreata from CTRL or skmSTX4tg mice were ﬁxed with 4% paraformaldehyde,
parafﬁn-embedded, and sectioned longitudinally at 5-μm thickness and 100-μm
intervals. The sectioned tissues were deparaﬁnized, rehydrated, blocked in 5%
horse serum, and incubated overnight at 4 °C with rabbit anti-insulin antibody54.
The beta cell area was calculated using the Keyence BZX-Analyzer version
1.3.1.1software. Data shown are representative of three pancreatic sections per
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mouse. The beta cell mass was calculated by multiplying the percentage of the islet
consisting of beta cells by the pancreas weight.
Islet isolation and insulin secretion. Intact pancreatic islets were isolated from
CTRL (non-Dox-treated) and skmSTX4tg (Dox-treated) mice using collagenase
digestion and separation from acinar tissue and debris on Ficoll gradients, followed
by hand-picking under a stereomicroscope55. Islets were cultured overnight in
RPMI 1640 medium (containing 10% FBS, 100 U/ml penicillin, and 100 µg/ml of
streptomycin). On the following day, the islets were incubated in 500 μ1 KrebsRinger-Bicarbonate-HEPES buffer (KRBH)/Eppendorf tube (25 islets/condition)
without glucose for 1 hour, followed by incubation in low (1 mM) and high
(20 mM) glucose for 30 min. Insulin assays of the supernatant were performed
using a BioTek Synergy (Winooski, VT, USA) HTX Multi-Mode Plate Reader and
the Mouse Insulin ELISA kit (Mercodia #10-1247-01; Winston Salem, NC, USA).
Metabolic caging and body composition analysis. Male mice were metabolically
phenotyped during the feeding study, starting at 8 weeks of age (after the chow
diet), 18 weeks (after the HFD), or 24 weeks of age (after continuation of the HFD
without or with STX4 induction). Mice were weighed, then individually housed in
metabolic cages (Phenomaster; TSE Systems, Bad Homburg, Germany) with ad
libitum access to food and water for the duration of the experiment. The mice were
acclimatised to the cages for 1 day and experimental datasets were collected for the
next 24-48 hours. The lights were on from 6:00 to 18:00. The following parameters
were monitored: food intake, water consumption, oxygen intake, carbon dioxide
production, and ambulatory activity. AUC for RER was calculated with 0.7 set to
the y-axis, while EE y = 0. AUC was calculated using the area under the curve
parameter in Graphpad prism software. Animals were observed daily and body
weight was evaluated at the conclusion of the experiment. Whole-body composition (fat and lean tissues) was determined using quantitative magnetic resonance
technology (EchoMRI 3-in-1; Echo Medical Systems, Houston, TX).
Extracellular ﬂux analysis (Seahorse). Flexor digitorum brevis (FDB) muscle
was extracted from both legs of 24-week-old HFD-fed male mice (skmSTX4tg HFD
and HFD + STX4) and dissociated in 4 mg/ml collagenase (Sigma, #C-0130) for
2 h. After dissociation, the muscle ﬁbres were cleaned and transferred into
immersion media. The myoﬁbers (100 µl/well) were plated in a 24-well Agilent
Seahorse eXF24 plate with 10 µl Matrigel in every well. The cells were left to adhere
overnight and were analysed in the Agilent extracellular ﬂux analysis machine
(XFe24) after treatment with oligomycin (4 μM), FCCP (1 μM), pyruvate (10 μM),
and rotenone antimycin A (0.5 μM) at time intervals to assess mitochondrial
function. The cells were lysed with 1% NP-40 lysis buffer and the OCR was
normalised to protein content. The data were analysed using a wave 2.6.0 software
(Agilent, Santa Clara, CA). The results are derived from independent assays of 3
mice and normalised to baseline OCR.
Citrate synthase activity measurement. TA or whole-hindlimb muscle was
homogenised (300 µl TA, 2 ml HL) in ice-cold buffer (50 mM Tris, pH 7.0, 150 mM
KCl), and the protein concentration was determined using the BCA Protein Assay
(Thermo Scientiﬁc). Citrate synthase activity was measured by coupling conversion
of oxaloacetate to acetyl-CoA with reduction of 5,5′-dithiosbis (2-nitrobenzoic
acid) (DTNB) (Sigma-Aldrich). Protein (20 μg) was added to a 150 μl reaction mix
(0.1 mM DTNB, 0.25% Triton X-100, 0.5 mM oxaloacetate and 0.25 mg/ml acetylCoA in 0.1 M Tris, 7.4) and product formation was measured at 412 nm over 300 s
on a Tecan Inﬁnite M200 PRO plate reader. Results were calculated from a constant rate and an extinction coefﬁcient (εB) 13.6 mM-1•cm-1. Assays were repeated
in duplicate, and 2 separate reactions were conducted, at 3 min and 4.5 min56.
Mitochondrial copy number evaluation. DNA was isolated from mouse whole
hindlimb, and then analysed by quantitative PCR using SYBR green (Bio-Rad
#170-8880) and processed on QuantStudio3 (Applied Biosystems). The abundance
of mitochondrial-encoded cytochrome oxidase I subunit (COX1) was compared
with the nuclear 18 S rRNA to give the mitochondrial DNA abundance. The mouse
COX1 primers were 5′-ACCATCATTTCTCCTTCTCCTA-3′ and 5′-TAGATTTC
CGGCTAGAGGTG-3′ and the mouse 18 S primers were 5′-TGGCTCATTAA AT
CAGTTATGGT-3′ and 5′-GTCGGCATGTATTAGCTCTAG-3′, as described57.
Transmission electron microscopy. Mouse tissues were dissected and immediately ﬁxed with 2.5% glutaraldehyde, 4% paraformaldehyde in 0.1 M sodium
cacodylate buffer (Na(CH3)2AsO2 •3H2O), pH 7.2, at 4°C. Standard tissue sample
preparation for TEM was followed including post-ﬁxation with osmium tetroxide,
serial dehydration with ethanol, and embedment in Eponate58. Ultra-thin sections
(~70 nm thick) were acquired by ultramicrotomy, post-stained, and examined on
an FEI Tecnai 12 transmission electron microscope equipped with a Gatan
Ultrascan 2 K CCD camera.
Immunogold staining. Mouse muscle tissues were dissected and immediately ﬁxed
with 0.2% glutaraldehyde, 4% paraformaldehyde in phosphate-buffered saline
(PBS), pH 7.4, at 4 °C. The tissues were then sectioned into 150-µm-thick sections
12

using a Leica Vibratome. Pre-embedding immune-labelling was performed on the
vibratome sections using rabbit anti-STX4 primary antibody (Millipore Sigma
#AB5330) and Nanogold® anti-rabbit IgG (Nanoprobes) diluted 1:100 in PBS for
1.5 h. HQ Silver enhancement kit (Nanoprobes) was used to further develop the
Nanogold® staining. The vibratome sections were then processed following standard sample preparation for TEM and examined as described above.
Mitochondrial area analysis. The mitochondrial area was calculated using the
‘measure’ macro in ImageJ version 1.45 s software. Four to six images per mouse at
6500X magniﬁcation were counted, and then converted to mm2 by dividing by the
number of pixels of the scale bar. Three to six mice were counted per condition.
Conditioned media assay. L6 GLUT4myc cells and INS-1 832/13 cells were
authenticated by the cell morphology using microscopy. Low passages of cells were
kept frozen. L6 skeletal muscle myoblasts were transfected with, pCDNA and
pCDNA STX4 for 48 h and media was harvested. Myoblast media (250 μl), plus
250 μl low glucose (2.5 mM) and low serum (2.5%) RPMI (INS-1 derived 832/13
cell) media were mixed (equal ratios) and incubated with INS-1 832/13 cells
(provided by Dr. Christopher Newgard (Duke University Medical Center, Durham,
NC) for 16 hours. The media was washed after 16 hours and incubated in KrebsRinger bicarbonate buffer (KRBB) for 1 h. Further, the cells were incubated in 1 mM
or 20 mM glucose-containing KRBB for 30 min and the supernatants were collected
for GSIS. Insulin released into the media was assessed by rat insulin ELISA kit.
Muscle mitochondrial fractionation assay. Isolation of mouse skeletal muscle
mitochondrial was performed as previously described59. Brieﬂy, total hindlimb
muscles from C57BL/6 mice were minced on ice in Buffer A (220 mM mannitol,
100 mM sucrose, 100 mM Tris-HCl, 1 mM EGTA, pH 7.4) and transferred to
centrifuge tubes using 5 ml HM (250 mM sucrose, 100 mM Tris-HCl, 2 mM EGTA,
pH 7.4). Two-stage polytron homogenization and centrifugation were performed as
published60. The mitochondrial pellet was resuspended in Buffer B (220 mM
mannitol, 70 mM sucrose, 20 mM Tris- Cl, 0.02 mM EDTA, 0.2% fatty acid-free
BSA, pH 7.4). Protein concentration was determined by Micro BCA Protein Assay
(Thermo Fisher Scientiﬁc, Rockford, IL, USA).
Co-immunoprecipitation. Three mg of mouse whole-hindlimb extract was immunoprecipitated by incubating the lysate with 3 µg of STX4 antibody (Millipore Sigma,
#AB5330) overnight rotating at 4 °C, followed by incubation with 80 µl of Protein-G
Agarose beads for 2 h, rotating at 4 °C. Immunoprecipitated proteins were washed three
times with lysis buffer on ice and eluted with SDS sampling buffer containing DTT.
Eluted proteins were resolved by 10% SDS-PAGE hand-cast gel overnight at 7 V, and
then transferred the next day to PVDF membranes activated with methanol and rapidly
rinsed in TBS, pH7.4. The gel was transferred overnight, at which time Ponceau S
staining was used to evaluate protein loading, and immunoblotting was conducted
according to the previously stated method. Mouse muscle mitochondrial fractions
(0.5 mg protein per reaction) was incubated with 0.5 μg of STX4 antibody (Millipore
Sigma) overnight at 4 °C. The mixtures of protein and antibody were immunoprecipitated by incubating 80 μl of Protein-G Agarose beads for 2 h at 4 °C. The complex was
eluted with SDS sample buffer containing DTT and proteins resolved by 12% SDSPAGE. The gel was transferred to PVDF followed by immunoblotting.
Statistics. All data are presented as mean ± SEM. Student’s t-test was used for
single comparisons, and ANOVA was used for multiple comparisons. Tukey’s post
hoc method was used for individual comparisons after one-way ANOVA. P < 0.05
was considered signiﬁcant using GraphPad Prism software, version 7.02 (unless
otherwise speciﬁed).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
All data generated or analysed during this study are included in this published article
(and its supplementary information ﬁles). Source data are provided with this paper.
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